Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:12 AM
Ignite Modification Date:
2025-12-25 @ 2:12 AM
NCT ID:
NCT06873360
Eligibility Criteria:
Inclusion Criteria:
* Outpatient patient with gastrointestinal cancer treated with oxaliplatin.
* Having completed at least three cycles of chemotherapy.
* Presenting acute or chronic symptoms of chemotherapy-induced peripheral neuropathy.
* The study will include individuals over 18 years old. Gender identify will be collected confidentially and inclusively, offering options for non-binary individuals and those who prefer not to identify with binary categories.
Exclusion Criteria:
* Patient with osteoarthritis or arthritis in the hands.
* Diagnosis of any autoimmune disease affecting connective tissue, such as: rheumatoid arthritis, Raynaud's syndrome, lupus, scleroderma, dermatomyositis, vasculitis, or cryoglobulinemia.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT06873360
Study Brief:
Protocol Section:
NCT06873360